Uncategorized
Selank: The Anxiolytic Peptide for Stress and Cognitive Research
Selank: The Anxiolytic Peptide for Stress and Cognitive Research
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed as an analog of tuftsin, an immunomodulatory peptide. It has gained attention for its anxiolytic (anti-anxiety) and cognitive-stabilizing properties, with a clinical history in Russia spanning more than two decades. Unlike classical benzodiazepines, Selank is reported to reduce anxiety without significant sedation or dependence, making it a prominent subject in anxiolytic peptide research.
1. What Is Selank?
Selank is a nootropic anxiolytic peptide derived from tuftsin, with the addition of a proline-glycine-proline stabilizer tail (shared with Semax). It was developed at the Institute of Molecular Genetics in Moscow and is registered in Russia as a pharmaceutical for anxiety spectrum disorders. Its unique profile combines anxiolytic, nootropic, and immunomodulatory activity.
- Peptide type: Synthetic anxiolytic nootropic (tuftsin analog)
- Forms: Standard Selank, N-Acetyl Selank, Selank Amidate (stability-enhanced analogs)
- Administration: Intranasal (clinical) or subcutaneous injection (research)
- Half-life: Short circulating half-life; analogs extend duration
- Status: Registered pharmaceutical in Russia; research compound elsewhere
2. Mechanism of Action
Selank modulates anxiety through a distinct mechanism that does not rely on benzodiazepine receptor agonism:
- GABAergic modulation: Influences GABA-A receptor system activity and anxiety circuits
- BDNF and neuroplasticity: Increases BDNF levels, supporting stress resilience and cognitive function
- Monoamine balance: Modulates serotonin and dopamine turnover, contributing to mood stabilization
- Immunomodulation: Regulates cytokine balance, including IL-6, linking immune and stress responses
3. The Research Landscape
| Research area | Reported findings |
|---|---|
| Anxiety disorders | Clinically evaluated for generalized anxiety with favorable tolerability |
| Cognitive stabilization | Reported improvement in attention and memory under stress |
| Stress resilience | Animal models show reduced anxiety-like behavior without sedation |
| Addiction research | Studied in withdrawal and craving modulation protocols |
Selank’s clinical track record in Russia provides a comparatively long safety history, while its mechanisms continue to be investigated internationally.
4. Research Applications
- Anxiolytic research: Models of generalized anxiety, situational stress, and performance anxiety
- Nootropic research: Cognitive stabilization under stress and sleep deprivation
- Neuroimmune research: Effects on cytokine balance and stress-immune crosstalk
- Addiction research: Craving reduction and withdrawal symptom modulation
For related mental wellbeing peptides, see our peptides for anxiety and mental wellbeing guide.
5. Dosing and Protocol Notes
- Clinical intranasal dose: 200-900 mcg/day, divided into 2-3 administrations
- Research injection protocols: 200-500 mcg subcutaneous, often in 10-20 day cycles
- Reconstitution: Use bacteriostatic water; see our reconstitution and dosage guide
- Cycling: Washout periods between cycles are commonly used in research
6. Side Effects and Considerations
- Low sedation profile: Distinct from benzodiazepines; minimal daytime drowsiness reported
- Mild effects: Occasional headache or nasal irritation with intranasal use
- Low abuse potential: No significant dependence liability reported in clinical use
- Contraindications: Pregnancy, lactation, and severe hepatic or renal dysfunction
7. Frequently Asked Questions
Is Selank addictive? Clinical evidence indicates a low dependence profile compared with benzodiazepines, though long-term effects remain under study.
How does Selank compare with Semax? Both share the same stabilizing tail and are often studied together; Selank is primarily anxiolytic, while Semax is more strongly nootropic and neuroprotective.
What is the onset of effects? Users typically report anxiolytic effects within minutes to an hour after intranasal administration.
Related Reading
- Peptides for Anxiety and Mental Wellbeing
- Peptides for Cognitive Function and Brain Health
- Peptides for Sleep and Recovery
- Peptide Safety and Side Effects Guide
Shop Related Research Compounds
Browse our research catalog, including Selank, Semax, and DSIP, all supplied with batch COAs.
Disclaimer: This article is for educational and research purposes only. Selank is a research compound not approved for general human use outside its registered jurisdiction. Always consult qualified professionals regarding research protocols.
